Is Global Alliance For Tb Drug Development Inc Legit?
Quick charity verification for Global Alliance For Tb Drug Development Inc (EIN: 134128413)
Verdict: Global Alliance For Tb Drug Development Inc appears trustworthy
95/100Mission Score
$202.5MRevenue
$204.3MAssets
1Red Flags
5Strengths
Red Flags
Unusually low (0%) reported officer compensation, which may obscure actual executive remuneration if it's categorized elsewhere.
Strengths
Consistent financial health with revenues generally exceeding expenses.
Strong and growing asset base, reaching $197,319,541 in 2023.
Reported 0% officer compensation, indicating a strong focus on program spending.
Effective management of significant revenue fluctuations, as seen in 2019.
Low liabilities relative to assets, suggesting financial stability (e.g., $25,619,991 liabilities vs. $197,319,541 assets in 2023).
Spending Breakdown
How Global Alliance For Tb Drug Development Inc allocates its funds across programs, administration, and fundraising.
100%
Program Spending
Healthy — majority goes to mission
0%
Admin Costs
Reasonable — admin costs in check
0%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.
How to Interpret This Report
What Red Flags Mean
Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.
What Mission Score Measures
The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.
Using This Data for Donation Decisions
Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.
Frequently Asked Questions about Global Alliance For Tb Drug Development Inc
Is Global Alliance For Tb Drug Development Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Global Alliance For Tb Drug Development Inc (EIN: 134128413) appears trustworthy. Mission Score: 95/100. 1 red flag identified, 5 strengths noted.
Is Global Alliance For Tb Drug Development Inc a good charity to donate to?
Global Alliance For Tb Drug Development Inc has a Mission Score of 95/100. Revenue: $202.5M. Assets: $204.3M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.
What is the EIN for Global Alliance For Tb Drug Development Inc?
The Employer Identification Number (EIN) for Global Alliance For Tb Drug Development Inc is 134128413. This is the unique tax ID assigned by the IRS.
What is a Mission Score?
The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.
How does Global Alliance For Tb Drug Development Inc spend its money?
Global Alliance For Tb Drug Development Inc allocates 100% to programs, 0% to administration, and 0% to fundraising. Healthy nonprofits typically spend 75%+ on programs.
How can I verify Global Alliance For Tb Drug Development Inc's tax-exempt status?
You can verify Global Alliance For Tb Drug Development Inc's tax-exempt status using EIN 134128413 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.
AI Transparency Report
Global Alliance For Tb Drug Development Inc demonstrates strong financial health and a consistent commitment to its program services. Over the past five years (2019-2023), the organization has consistently reported revenues exceeding expenses, leading to a healthy growth in assets from $189,418,881 in 2019 to $197,319,541 in 2023. The significant revenue spike in 2019 to $174,873,899, compared to typical annual revenues around $60 million, suggests successful grant acquisition or major fundraising efforts in that period, which were effectively managed as expenses remained controlled.
The organization's spending efficiency appears robust, with a high proportion of expenses dedicated to program services. The consistent reporting of 0% officer compensation across all available filings is a notable indicator of transparency and a focus on mission-driven spending rather than executive enrichment. This practice, while unusual, suggests that executive leadership may be compensated through other means not categorized as 'officer compensation' or that the organization relies heavily on volunteer leadership or external contractors for executive functions, which would warrant further investigation for complete transparency.
Overall, Global Alliance For Tb Drug Development Inc exhibits sound financial management, a strong asset base, and a clear dedication to its programmatic goals, as evidenced by its consistent financial performance and the absence of reported officer compensation. The organization's ability to maintain substantial assets while consistently funding its operations indicates a sustainable financial model.